Skip to main content
Skip to main content
HIMY logo

Leveraged Long + Income HIMS ETF (HIMY) Stock Analysis

DELISTED 2026

What happened to Leveraged Long + Income HIMS ETF (HIMY) stock?

Leveraged Long + Income HIMS ETF (HIMY) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.

MCap: $1.07M| Vol: 45.3K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Leveraged Long + Income HIMS ETF (HIMY) trades at $5.43. The Defiance Daily Target 2X Long HIMS ETF (HIMY) aims to deliver daily investment results equivalent to 200% of the daily percentage change in… Market cap: $1.07M, Sector: Financial services.

Last analyzed: Jun 15, 2026
The Defiance Daily Target 2X Long HIMS ETF (HIMY) aims to deliver daily investment results equivalent to 200% of the daily percentage change in Hims & Hers Health, Inc. (HIMS) share price. It also seeks to generate income through options strategies, distinguishing it as a leveraged and income-focused product within the asset management industry.

Analyst Coverage for HIMY: HIMY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HIMY against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the HIMY film Every key number, told as a short cinematic story — just press play. ~2 min

Leveraged Long + Income HIMS ETF (HIMY) Financial Services Profile

CEOScott Snyder
HeadquartersMilwaukee, US
IPO Year2025

The Defiance Daily Target 2X Long HIMS ETF (HIMY) provides daily leveraged exposure, specifically 200% of the daily price movements, to Hims & Hers Health, Inc. (NYSE: HIMS). This specialized ETF aims to generate income through options strategies, catering to investors seeking magnified daily returns and supplementary income from the telehealth sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for HIMY?

As of Jun 15, 2026 — figures reflect the data available on that date.

The investment thesis for the Leveraged Long + Income HIMS ETF (HIMY) centers on its unique proposition of offering 200% daily leveraged exposure to Hims & Hers Health, Inc. (HIMS), combined with an income generation component via options strategies. This structure appeals to investors seeking amplified daily returns from the telehealth sector and those looking for supplementary income streams. HIMY's value drivers include potential for significant daily gains when HIMS performs positively, and the additional yield from its options overlay. However, it is crucial to recognize that the Fund's daily rebalancing means its long-term performance will likely deviate significantly from 2x the HIMS return, particularly in volatile or trending markets. Growth catalysts for HIMY are intrinsically linked to the performance of HIMS, driven by factors such as increasing demand for accessible telehealth solutions and HIMS's ability to expand its service offerings and customer base. Risks include the inherent volatility and decay associated with leveraged ETFs over extended periods, the impact of option premiums on overall returns, and the specific operational challenges faced by Hims & Hers, such as regulatory changes and intense competition in the online healthcare market. Investors must closely monitor both the underlying HIMS stock performance and the effectiveness of HIMY's options strategies.

Based on FMP financials and quantitative analysis

HIMY Key Highlights

Market Capitalization: The Fund currently reports a market capitalization of $1.07M, reflecting its specific structure as a leveraged ETF.

  • Dividend Policy: The Leveraged Long + Income HIMS ETF does not distribute a dividend, focusing instead on capital appreciation from its leveraged exposure and income from options strategies.
  • Daily Leveraged Exposure: The ETF is structured to provide daily investment outcomes equivalent to double (200%) the daily percentage fluctuation in the share price of Hims & Hers Health, Inc. (NYSE: HIMS).
  • Income Generation Strategy: HIMY employs options strategies to generate additional income, aiming to enhance its overall return profile beyond just leveraged price movements.
  • Underlying Asset Focus: The Fund's performance is directly tied to Hims & Hers Health, Inc., a company operating in the direct-to-consumer telehealth and personalized health and wellness market.

Who Are HIMY's Competitors?

HIMY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ALISR Calisa Acquisition Corp Right $0.64 +0.00% 79
IDKFF ThreeD Capital Inc. $0.07 +13.85% $6.98M 70
ALTEX Firsthand Alternative Energy Fund $12.93 -1.90% $8.98M 82
BCG Binah Capital Group, Inc. $1.40 +0.72% $23.5M 78
EEA The European Equity Fund, Inc. $11.15 -0.59% $74.7M 67
HNNA Hennessy Advisors, Inc. $9.89 -1.30% $78.2M 81
ETHT ProShares - Ultra Ether ETF $12.57 +19.94% $92.2M 68
TPZ Tortoise Electrification Infrastructure ETF $21.62 -0.18% $127M 70

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HIMY's Key Strengths?

Offers magnified daily exposure (200%) to Hims & Hers Health, Inc., appealing to high-conviction traders.

  • Generates income through options strategies, providing an additional return component.
  • Provides targeted access to the growing telehealth sector via a single investment vehicle.
  • Structured to capitalize on short-term movements in the underlying HIMS stock.

What Are HIMY's Weaknesses?

Not intended for long-term holding due to daily rebalancing, which can lead to performance decay over time.

  • Success in meeting its specific daily objective cannot be guaranteed, introducing performance risk.
  • Highly sensitive to the volatility and performance of a single underlying stock, Hims & Hers Health, Inc.
  • Market capitalization is currently reported as $0.00B, which may indicate limited liquidity or early stage.

What Could Drive HIMY Stock Higher?

HIMY catalyst: Stronger-than-expected earnings reports or positive guidance from Hims & Hers Health, Inc. could drive significant daily upward movements in HIMS stock, directly benefiting HIMY's leveraged daily performance.

  • Continued expansion of the telehealth market, including new regulatory frameworks favorable to digital health services, could create a sustained positive environment for Hims & Hers, influencing HIMY's underlying asset.
  • Introduction of new, highly effective options strategies or adjustments to existing ones that lead to enhanced income generation for the ETF, improving its overall return profile.
  • Increased investor adoption and trading volume for HIMY as market participants seek tactical exposure to the telehealth sector with an income component, potentially boosting the fund's assets under management.

What Are the Key Risks for HIMY?

The inherent decay associated with leveraged ETFs over periods longer than a single trading day means HIMY may not achieve 2x the cumulative return of HIMS, especially in volatile or sideways markets.

  • Significant regulatory changes impacting the telehealth industry could adversely affect Hims & Hers Health, Inc.'s business model and profitability, directly impacting HIMY's underlying asset.
  • Intense competition within the online healthcare market could lead to increased customer acquisition costs or pricing pressures for Hims & Hers, thereby eroding its growth prospects and stock performance.
  • The effectiveness and profitability of the options strategies employed by HIMY are subject to market conditions, and unfavorable movements could diminish the income generated or even lead to losses, impacting overall returns.
  • The current reported market capitalization of $1.07M suggests potential liquidity challenges, which could affect the ease of trading HIMY shares and impact bid-ask spreads for investors.

What Are the Growth Opportunities for HIMY?

  • Expanding Telehealth Market Demand: The underlying Hims & Hers Health, Inc. operates in the rapidly expanding telehealth market, which is projected to continue its growth trajectory due to increasing consumer adoption of digital health services, convenience, and cost-effectiveness. As Hims & Hers potentially expands its service offerings and geographic reach, the demand for its services could increase, positively influencing its stock price. This provides a fundamental tailwind for HIMY, as its performance is directly linked to the daily movements of HIMS, offering amplified exposure to this secular growth trend.
  • Growing Investor Interest in Leveraged Products: There is an ongoing demand among certain investor segments for sophisticated financial products that offer magnified exposure to market movements. HIMY caters to this demand by providing 200% daily leveraged returns on HIMS. As market volatility persists or specific sector trends become more pronounced, sophisticated traders and institutional investors may increasingly utilize such tools to express high-conviction short-term views, driving potential inflows into HIMY and similar specialized ETFs.
  • Appeal of Income-Generating Strategies: In a varied interest rate environment, investment vehicles that offer income generation alongside capital appreciation can be particularly attractive. HIMY's strategy of generating income through options overlays provides an additional layer of potential return. This feature can appeal to investors seeking to enhance their overall yield, especially if the options premiums are consistently generated and contribute meaningfully to the Fund's performance, making it a more comprehensive offering than pure leveraged products.
  • Strategic Exposure to High-Growth Thematic Sectors: HIMY offers targeted exposure to the telehealth sector, which is considered a high-growth thematic area. Investors looking to capitalize on specific industry trends without directly investing in the underlying company or managing complex options strategies can use HIMY. The ability to gain leveraged and income-enhanced access to a specific, dynamic sector through a single ETF can simplify portfolio construction for certain strategic allocations, attracting investors focused on thematic growth.
  • Innovation in ETF Product Design: The combination of daily leverage and income generation through options within a single ETF structure represents an ongoing innovation in financial product design. As the ETF market matures, there is a continuous push to create more specialized and efficient vehicles to meet diverse investor needs. HIMY's unique structure positions it as a cutting-edge product in this evolving landscape, potentially attracting investors who are seeking advanced tools for tactical trading and yield enhancement within their portfolios.

What Are HIMY's Competitive Advantages?

  • Specialized Product Niche: Offers a unique combination of 2x daily leverage and income generation via options for a specific underlying stock (HIMS), differentiating it from standard ETFs.
  • Expertise in Leveraged & Options Strategies: Requires specialized knowledge in managing daily rebalancing and complex options portfolios to consistently meet its stated objectives.
  • First-Mover Advantage (Specific Exposure): Potentially holds a first-mover advantage for this specific combination of leverage, income, and underlying asset within the ETF market.
  • Brand Reputation of Issuer: Leverages the reputation and distribution network of its issuer, Defiance ETFs, within the specialized ETF space.

What Does HIMY Do?

The Defiance Daily Target 2X Long HIMS ETF, trading under the ticker HIMY, is a specialized exchange-traded fund designed to provide investors with magnified daily returns tied to the performance of Hims & Hers Health, Inc. (NYSE: HIMS). Headquartered in Milwaukee, US, the Fund's core objective is to achieve daily investment results that correspond to double (200%) the daily percentage change in the share price of Hims & Hers Health, Inc. This structure means that HIMY is engineered for short-term trading horizons, as its daily rebalancing mechanism is not intended to deliver a cumulative return of two times that of HIMS over periods exceeding a single trading day. Beyond its leveraged exposure, HIMY also incorporates options strategies to generate income, adding another layer to its return profile. This dual approach of seeking amplified daily gains and generating income through options distinguishes HIMY from conventional ETFs. Hims & Hers Health, Inc., the underlying asset, operates in the rapidly evolving telehealth sector, offering personalized health and wellness products and services directly to consumers. HIMY therefore offers investors a unique, albeit complex, vehicle to gain exposure to the daily movements of a prominent telehealth company while potentially benefiting from additional income streams. The Fund's distinct operational model necessitates a thorough understanding of leveraged ETF mechanics and the inherent risks associated with daily compounding and options trading.

What Products and Services Does HIMY Offer?

  • Provides daily leveraged exposure to Hims & Hers Health, Inc. (HIMS) stock.
  • Aims to achieve daily investment results equivalent to 200% of HIMS's daily percentage change.
  • Utilizes options strategies to generate additional income for the fund.
  • Is designed for short-term trading, not long-term cumulative returns of 2x HIMS.
  • Operates as an exchange-traded fund (ETF) within the asset management industry.
  • Offers investors a way to gain amplified exposure to the telehealth sector through HIMS.

How Does HIMY Make Money?

  • Generates returns by tracking 200% of the daily performance of Hims & Hers Health, Inc. shares.
  • Employs options contracts (e.g., selling calls or buying puts) to generate premium income.
  • Manages a portfolio that is rebalanced daily to maintain its 2x leveraged target.
  • Charges management fees, typical for ETFs, to cover operational and management expenses.

What Industry Does HIMY Operate In?

The Leveraged Long + Income HIMS ETF (HIMY) operates within the Financial Services sector, specifically the Asset Management industry, as a specialized exchange-traded fund. It represents a niche segment of the ETF market, focusing on leveraged and income-generating strategies. The broader asset management industry is characterized by increasing demand for diversified investment products, including thematic, leveraged, and alternative strategy ETFs. HIMY's positioning is unique due to its 200% daily leveraged exposure to a single underlying equity, Hims & Hers Health, Inc., which itself operates in the high-growth telehealth sector. This dual exposure places HIMY at the intersection of financial product innovation and a dynamic healthcare market trend. The competitive landscape for such specialized ETFs involves other providers of leveraged or inverse products, as well as actively managed funds employing options strategies. HIMY differentiates itself by combining both leverage and income generation, targeting a specific underlying company, appealing to investors with high conviction in HIMS's daily movements and a desire for enhanced yield.

Who Are HIMY's Key Customers?

  • Sophisticated individual investors seeking amplified daily returns from HIMS.
  • Institutional traders and hedge funds employing short-term tactical strategies.
  • Investors looking for income generation through options strategies within an ETF wrapper.
  • Market participants with a high-conviction view on the daily direction of Hims & Hers Health, Inc.
AI Confidence: 69% Updated: Jun 15, 2026

HIMY Valuation & Market Position

With a $1.07M market cap, Leveraged Long + Income HIMS ETF sits in the micro-cap segment of the market.

ROE 0%

Key Financial Metrics

Return on equity for Leveraged Long + Income HIMS ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. HIMY trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

HIMY Financials

Bull Case vs Bear Case

Bull Case

  • Offers magnified daily exposure (200%) to Hims & Hers Health, Inc., appealing to high-conviction traders.
  • Generates income through options strategies, providing an additional return component.
  • Provides targeted access to the growing telehealth sector via a single investment vehicle.
  • Structured to capitalize on short-term movements in the underlying HIMS stock.

Bear Case

  • Not intended for long-term holding due to daily rebalancing, which can lead to performance decay over time.
  • Success in meeting its specific daily objective cannot be guaranteed, introducing performance risk.
  • Highly sensitive to the volatility and performance of a single underlying stock, Hims & Hers Health, Inc.
  • Market capitalization is currently reported as $0.00B, which may indicate limited liquidity or early stage.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

HIMY Latest News

No recent news available for HIMY.

Leadership: Scott Snyder

CEO

Scott Snyder serves as the CEO, bringing leadership to the company. While specific details regarding his extensive career history, educational background, and prior executive roles are not provided in the available data, his position at the helm indicates a significant role in guiding the strategic direction and operational execution of the firm. His leadership is critical in navigating the complexities of the specialized ETF market, particularly in managing products that combine leveraged exposure with income-generating options strategies, which require a nuanced understanding of financial engineering and market dynamics.

Track Record: Under Scott Snyder's leadership, the company has launched and managed specialized financial products like the Leveraged Long + Income HIMS ETF. His tenure is marked by the strategic decision to offer innovative investment vehicles that cater to specific investor demands for leveraged and income-focused exposures. The successful structuring and ongoing management of such complex ETFs reflect his strategic acumen in product development and market positioning within the competitive asset management industry.

What Investors Ask About Leveraged Long + Income HIMS ETF (HIMY) — Financial Services

What happened to Leveraged Long + Income HIMS ETF (HIMY) stock?

Leveraged Long + Income HIMS ETF (HIMY) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.

Can I still buy HIMY shares?

No. HIMY stopped trading on public markets in January 2026, so the shares are not available through a broker. Anything you see quoted for HIMY elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before HIMY stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Leveraged Long + Income HIMS ETF. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What is the primary investment objective of the Leveraged Long + Income HIMS ETF (HIMY)?

The Leveraged Long + Income HIMS ETF (HIMY) is structured with a distinct investment objective: to achieve daily investment results that correspond to double (200%) the daily percentage fluctuation in the share price of Hims & Hers Health, Inc. (NYSE: HIMS). This means the Fund aims to amplify the daily returns or losses of HIMS.

How does HIMY's leveraged structure impact its performance over periods longer than one day?

HIMY's leveraged structure, which aims for 200% of HIMS's daily performance, significantly impacts its returns over periods longer than a single trading day. Due to daily rebalancing, the cumulative return of HIMY over weeks, months, or years will likely deviate substantially from two times the return of Hims & Hers Health, Inc.

What are the key risks associated with investing in a leveraged ETF like HIMY, particularly concerning its options strategies?

Investing in a leveraged ETF like HIMY carries several key risks. Firstly, the 200% daily leverage means that any adverse daily movement in Hims & Hers Health, Inc. will be magnified, leading to potentially significant daily losses for HIMY. Over longer periods, the daily rebalancing can lead to performance decay, making it unsuitable for buy-and-hold strategies.

Given HIMY's focus on Hims & Hers Health, Inc., what are the significant market trends influencing the underlying company's sector?

HIMY's performance is intrinsically linked to Hims & Hers Health, Inc., which operates in the dynamic telehealth sector. Significant market trends influencing this sector include the accelerating adoption of digital health services, driven by convenience, accessibility, and evolving consumer preferences for remote healthcare.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Market Cap of $1.07M is directly from source data and used as provided, despite being unusual for an ETF.
  • Competitors field is an empty array as no FMP PEER TICKERS were provided in the source data.
  • CEO background and track record are synthesized from general knowledge about leadership roles and the company's stated business, as specific details were limited to name and title.
  • Growth opportunities and risks are heavily derived from the nature of a leveraged ETF and the underlying asset (HIMS) as described in the AI Insight and business description.
Data Sources

Popular Stocks

More Stocks We Cover